Submitted by Anonymous (not verified) on 7 January 2026 - 16:05
Human medicines European public assessment report (EPAR): Herzuma, trastuzumab, Date of authorisation: 09/02/2018, Revision: 26, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Herzuma, trastuzumab, Date of authorisation: 09/02/2018, Revision: 26, Status: Authorised